Volume 13, Issue 1, Pages (July 2000)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

CD4+CD25+ Immunoregulatory T Cells
LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Volume 9, Issue 5, Pages (November 1998)
Autoantibodies in Scurfy Mice and IPEX Patients Recognize Keratin 14
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 10, Issue 1, Pages 9-19 (January 1999)
Volume 26, Issue 3, Pages (March 2007)
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
Volume 31, Issue 2, Pages (August 2009)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 16, Issue 2, Pages (February 2002)
Ling Lin, Jonathan D. Hron, Stanford L. Peng  Immunity 
Volume 20, Issue 4, Pages (April 2004)
Volume 18, Issue 5, Pages (May 2003)
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Volume 4, Issue 4, Pages (April 1996)
Volume 6, Issue 4, Pages (April 1997)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 21, Issue 2, Pages (August 2004)
Cyclin C/Cdk3 Promotes Rb-Dependent G0 Exit
Volume 9, Issue 5, Pages (November 1998)
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
Regulation of allergic airway inflammation by class I–restricted allergen presentation and CD8 T-cell infiltration  James W. Wells, PhD, Christopher J.
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
Monika Raab, Antonio J.da Silva, Paul R. Findell, Christopher E. Rudd 
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Volume 24, Issue 6, Pages (June 2016)
Volume 24, Issue 2, Pages (February 2006)
Volume 25, Issue 5, Pages (November 2006)
Volume 29, Issue 1, Pages (July 2008)
Volume 25, Issue 5, Pages (November 2006)
Volume 48, Issue 4, Pages e6 (April 2018)
Volume 29, Issue 1, Pages (July 2008)
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Volume 24, Issue 5, Pages (May 2006)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 15, Issue 4, Pages (August 2004)
Volume 21, Issue 2, Pages (August 2004)
Volume 32, Issue 5, Pages (May 2010)
Volume 9, Issue 5, Pages (November 1998)
Andrew T Miller, Heather M Wilcox, Zhongbin Lai, Leslie J Berg 
Volume 29, Issue 1, Pages (July 2008)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 47, Issue 4, Pages e6 (October 2017)
CTLA-4 Regulates Induction of Anergy In Vivo
Rsk1 mediates a MEK–MAP kinase cell survival signal
Volume 15, Issue 2, Pages (August 2001)
Volume 46, Issue 4, Pages (April 2017)
Silva H Hanissian, Raif S Geha  Immunity 
CD44 Regulates Survival and Memory Development in Th1 Cells
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10  Ela Martin, Brendan.
Volume 28, Issue 5, Pages (May 2008)
Volume 33, Issue 1, Pages (July 2010)
Volume 35, Issue 4, Pages (October 2011)
Volume 27, Issue 4, Pages (October 2007)
Notch 1 Signaling Regulates Peripheral T Cell Activation
The CD28 Signaling Pathway Regulates Glucose Metabolism
Luk Van Parijs, Alexander Ibraghimov, Abul K. Abbas  Immunity 
Volume 9, Issue 5, Pages (November 1998)
Mattias Svensson, Asher Maroof, Manabu Ato, Paul M. Kaye  Immunity 
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 39, Issue 1, Pages (July 2003)
Volume 24, Issue 6, Pages (June 2006)
Volume 14, Issue 3, Pages (March 2001)
Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,
Volume 17, Issue 6, Pages (December 2002)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 10, Issue 3, Pages (March 1999)
IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells  Arun K. Kannan, MS, Nisebita.
Presentation transcript:

Volume 13, Issue 1, Pages 95-105 (July 2000) The CD28-Related Molecule ICOS Is Required for Effective T Cell–Dependent Immune Responses  Anthony J Coyle, Sophie Lehar, Clare Lloyd, Jane Tian, Tracy Delaney, Stephen Manning, Trang Nguyen, Tim Burwell, Helga Schneider, Jose Angel Gonzalo, Michael Gosselin, Laura Rudolph Owen, Christopher E Rudd, Jose Carlos Gutierrez-Ramos  Immunity  Volume 13, Issue 1, Pages 95-105 (July 2000) DOI: 10.1016/S1074-7613(00)00011-X

Figure 1 Expression of ICOS in T Cell Subsets (A) Northern blot analysis of ICOS in Th1 clones (AE7 and Dorris) and Th2 clones (DAX, D10.G4, and CDC25) resting (minus) or 6 hr post CD3 stimulation (plus). Expression of GATA-3, IL-4, and IFNγ are shown for comparison. (B) ICOS expression is also shown in resting CD4 cells and CD3/TCR-activated antigen-specific Th1 and Th2 effector cells differentiated for one round of polarization derived from common T helper precursor cells. ICOS expression was quantified by phosphoimager analysis and is shown in (C). (D) Real-time PCR analysis (Taqman) of ICOS expression on resting CD4 cells and cells activated with PMA/ionomycin. Cells were also stimulated for 1, 3, or 5 days with peptide and APCs in either the absence of cytokines (open bars), IL-12 and anti-IL-4 (shaded bars), or IL-4 and anti-IL-12 (closed bars). All three populations were then rested overnight and activated for 6 hr with plate-bound CD3. ICOS expression is also shown in Th1 and Th2 cells that were differentiated for three rounds of repetitive stimulation and then activated by anti-CD3. Activated Th1 (AE7) and Th2 (D10.G4) clones are shown for comparison. Data are shown as expression relative to that detected in normal liver. Immunity 2000 13, 95-105DOI: (10.1016/S1074-7613(00)00011-X)

Figure 2 ICOS Associates with PI3K and Exhibits Lipid Hydrolysis Activity Left panel: Jurkat cells, stably transfected with empty PCDNA3 vector (lanes 1–3), ICOS (lanes 4–6), or the deletion mutant ICOSd180C (lanes 7–9) were either left unstimulated (lanes 1, 4) or stimulated with anti-CD28 (lanes 2, 3) or anti-Flag mAbs (lanes 5, 6, 8, 9) and rabbit anti-mouse antibody for 2 min (lanes 2, 5, 8) and 7.5 min (lanes 3, 6, 9). Following activation, cells were lysed, immunoprecipitated with CD28 mAb (lanes 1–3) or Flag mAb (lanes 4–9), and subjected to immunoblotting with p85 antiserum. The corresponding band recognized in cell lysate served as a positive control (lane 10). Right panel: cells were stimulated with anti-CD28 (lane 12) or anti-Flag mAbs (lanes 13, 14) and rabbit anti-mouse antibody for 2 min, lysed, immunoprecipitated with CD28 mAb (lane 12) or Flag mAb (lanes 13, 14), and subjected to a lipid kinase assay. Lane 11 represents a negative control; lane 15 represents a positive control for PI 3K. Immunity 2000 13, 95-105DOI: (10.1016/S1074-7613(00)00011-X)

Figure 3 Contribution of CD28 and ICOS to Activation of Either Naive or Recently Activated CD4+ T Cells (A) Proliferation and IL-2 secretion from resting CD4+ T cells activated with peptide in the presence of ICOS-Ig (open circles), CTLA-4Ig (closed squares), or hIg (open squares). Data are shown as triplicates of one of four representative experiments. (B) Inhibition of cytokine production from recently activated T cells. Data are shown as the percentage change in cytokine production in cells restimulated in the presence of ICOS-Ig (open squares) or CTLA-4-Ig (closed squares) compared to hIg. Levels of cytokines in control Ig-treated cells were IL-2, 1601 ± 123; IL-5, 1018 ± 35 pg/ml; IL-4, 1343 ± 20 pg/ml; and IFNγ, 2061 ± 172 pg/ml. Data are shown as one representative experiment of three similar experiments. Immunity 2000 13, 95-105DOI: (10.1016/S1074-7613(00)00011-X)

Figure 4 CD28 and ICOS Signaling to Th1 and Th2 Cells (A) Inhibition of cytokine production from an antigen-specific Th2 (D10.G4) but not a Th1 (AE7) clone by ICOS-Ig (closed columns) compared to hIg treated cells (open columns). (B) Cytokine production from reactivated Th1 and Th2 antigen-specific effector cells stimulated in the presence of ICOS-Ig (1–100 μg/ml) (open squares) or hIg (open bars). The effect of CTLA-4Ig is shown in closed bars for comparison. Data are shown as the mean ± SEM of triplicate wells and are representative of four different experiments. Immunity 2000 13, 95-105DOI: (10.1016/S1074-7613(00)00011-X)

Figure 5 CD28 and ICOS in T Cell–Dependent B Cell Activation Antibody isotype production in (A) primary and (B) secondary immune response induced by protein antigen administration. Mice were treated daily with hIg alone (open squares), CTLA-4Ig alone (open circles), ICOS-Ig alone (open diamonds), or CTLA-4Ig and ICOS-Ig in combination (open triangles). Data are shown as the mean ± SEM absorbance (OD) at serial sera dilution and represent data from n = 5–6 individual animals. Immunity 2000 13, 95-105DOI: (10.1016/S1074-7613(00)00011-X)

Figure 6 ICOS mRNA Expression in the Lungs after Adoptive Transfer of Th Effector Cells In situ analysis of ICOS mRNA expression in the lungs of Th2 recipient OVA-exposed mice hybridized with (A) ICOS antisense or (B) sense riboprobe. Th2 recipient mice that were exposed to PBS and hybridized with antisense ICOS are shown in (C). (D) illustrates that similar to in vitro activation, mice that received Th1 cells failed to express ICOS mRNA in the lungs after allergen challenge. Immunity 2000 13, 95-105DOI: (10.1016/S1074-7613(00)00011-X)

Figure 7 ICOS Blockade Selectively Inhibits Th2- but Not Th1-Mediated Inflammation and Altered Airway Responsiveness (A) Animals were treated with ICOS-Ig (shaded bars) or CTLA-4Ig (open bars), or hIg (closed bars) prior to allergen challenge in Th1 or Th2 recipient mice. Data are shown as the mean ± SEM of n = 4–6 mice and are representative of three different experiments. Significance (asterisk) was determined by a Student's t test, and a value of p < 0.05 was considered significant. (B) Exposure to OVA in both Th1 and Th2 recipient mice results in increased airway hyperresponsiveness to methacholine (20 mg/ml) as compared to PBS exposed mice. The baseline response is indicated in the open bars and the maximal response to inhaled methacholine is indicated in the closed bars. Significance (“#”) was determined by a Student's t test, and a value of p < 0.05 was considered significant. Control mice received hIg as the appropriate isotype control. Data are shown as the mean ± SEM of n = 3–6 mice and are representative of two different experiments. Significance from Ig-treated mice (asterisk) was determined by a Student's t test, and a value of p < 0.05 was considered significant. Immunity 2000 13, 95-105DOI: (10.1016/S1074-7613(00)00011-X)